27-08-2018
136
Global Drugs for Schistosomiasis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Scope of the Report:
This report focuses on the Drugs for Schistosomiasis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Drugs for Schistosomiasis is Praziquantel, Oxamniquine and other. Praziquantel is the mainly drug for Schistosomiasis, and the proportion of Praziquantel in 2015 is about 90%.
Drugs for Schistosomiasis are widely used in S. haematobium, S. mansoni, S. japonicum, S. mekongi and S. intercalatum.Most of human infections are caused by S. haematobium, S. mansoni, S. japonicum. And the market share used in S. haematobium in 2015 is 28%. And the market share used in S. mansoni in 2015 is 48%.
The worldwide market for Drugs for Schistosomiasis is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 100 million US$ in 2023, from 70 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Praziquantel
Oxamniquine
Other

Market Segment by Applications, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

There are 15 Chapters to deeply display the global Drugs for Schistosomiasis market.
Chapter 1, to describe Drugs for Schistosomiasis Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Schistosomiasis, with sales, revenue, and price of Drugs for Schistosomiasis, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Schistosomiasis, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Global Drugs for Schistosomiasis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023


Table of Contents

1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Business Overview
2.1.2 Drugs for Schistosomiasis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Drugs for Schistosomiasis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Drugs for Schistosomiasis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 EIPICO
2.4.1 Business Overview
2.4.2 Drugs for Schistosomiasis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Chandra Bhagat Pharma
2.5.1 Business Overview
2.5.2 Drugs for Schistosomiasis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Taj Pharmaceuticals
2.6.1 Business Overview
2.6.2 Drugs for Schistosomiasis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drugs for Schistosomiasis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2017
3.3.2 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Drugs for Schistosomiasis Market Analysis by Regions
4.1 Global Drugs for Schistosomiasis Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Schistosomiasis Sales and Market Share by Regions (2013-2018)
4.1.2 Global Drugs for Schistosomiasis Revenue and Market Share by Regions (2013-2018)
4.2 North America Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
4.3 Europe Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
4.5 South America Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
5 North America Drugs for Schistosomiasis by Countries
5.1 North America Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Schistosomiasis Sales and Market Share by Countries (2013-2018)
5.1.2 North America Drugs for Schistosomiasis Revenue and Market Share by Countries (2013-2018)
5.2 United States Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
5.3 Canada Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
5.4 Mexico Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
6 Europe Drugs for Schistosomiasis by Countries
6.1 Europe Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Schistosomiasis Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Drugs for Schistosomiasis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
6.3 UK Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
6.4 France Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
6.5 Russia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
6.6 Italy Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
7 Asia-Pacific Drugs for Schistosomiasis by Countries
7.1 Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Schistosomiasis Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Schistosomiasis Revenue and Market Share by Countries (2013-2018)
7.2 China Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
7.3 Japan Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
7.4 Korea Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
7.5 India Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
8 South America Drugs for Schistosomiasis by Countries
8.1 South America Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Schistosomiasis Sales and Market Share by Countries (2013-2018)
8.1.2 South America Drugs for Schistosomiasis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
8.3 Argentina Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
8.4 Colombia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
9 Middle East and Africa Drugs for Schistosomiasis by Countries
9.1 Middle East and Africa Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Schistosomiasis Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Schistosomiasis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
9.3 UAE Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
9.4 Egypt Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
9.5 Nigeria Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
9.6 South Africa Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
10 Global Drugs for Schistosomiasis Market Segment by Type
10.1 Global Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Schistosomiasis Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2013-2018)
10.2 Praziquantel Sales Growth and Price
10.2.1 Global Praziquantel Sales Growth (2013-2018)
10.2.2 Global Praziquantel Price (2013-2018)
10.3 Oxamniquine Sales Growth and Price
10.3.1 Global Oxamniquine Sales Growth (2013-2018)
10.3.2 Global Oxamniquine Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Drugs for Schistosomiasis Market Segment by Application
11.1 Global Drugs for Schistosomiasis Sales Market Share by Application (2013-2018)
11.2 S. haematobium Sales Growth (2013-2018)
11.3 S. mansoni Sales Growth (2013-2018)
11.4 S. japonicum Sales Growth (2013-2018)
11.5 S. mekongi Sales Growth (2013-2018)
11.6 S. intercalatum Sales Growth (2013-2018)
12 Drugs for Schistosomiasis Market Forecast (2018-2023)
12.1 Global Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Schistosomiasis Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Schistosomiasis Market Forecast (2018-2023)
12.2.2 Europe Drugs for Schistosomiasis Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Schistosomiasis Market Forecast (2018-2023)
12.2.4 South America Drugs for Schistosomiasis Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Schistosomiasis Market Forecast (2018-2023)
12.3 Drugs for Schistosomiasis Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Schistosomiasis Market Share Forecast by Type (2018-2023)
12.4 Drugs for Schistosomiasis Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Schistosomiasis Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure Global Sales Market Share of Drugs for Schistosomiasis by Types in 2017
Table Drugs for Schistosomiasis Types for Major Manufacturers
Figure Praziquantel Picture
Figure Oxamniquine Picture
Figure Other Picture
Figure Drugs for Schistosomiasis Sales Market Share by Applications in 2017
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure United States Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure France Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure UK Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure China Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure India Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2013-2023)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Global Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Global Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Global Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Global Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Global Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Figure Top 3 Drugs for Schistosomiasis Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Drugs for Schistosomiasis Manufacturer (Revenue) Market Share in 2017
Figure Global Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Global Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table Global Drugs for Schistosomiasis Sales by Regions (2013-2018)
Table Global Drugs for Schistosomiasis Sales Market Share by Regions (2013-2018)
Table Global Drugs for Schistosomiasis Revenue by Regions (2013-2018)
Figure Global Drugs for Schistosomiasis Revenue Market Share by Regions in 2013
Figure Global Drugs for Schistosomiasis Revenue Market Share by Regions in 2017
Figure North America Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure South America Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure North America Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table North America Drugs for Schistosomiasis Sales by Countries (2013-2018)
Table North America Drugs for Schistosomiasis Sales Market Share by Countries (2013-2018)
Figure North America Drugs for Schistosomiasis Sales Market Share by Countries in 2013
Figure North America Drugs for Schistosomiasis Sales Market Share by Countries in 2017
Table North America Drugs for Schistosomiasis Revenue by Countries (2013-2018)
Table North America Drugs for Schistosomiasis Revenue Market Share by Countries (2013-2018)
Figure North America Drugs for Schistosomiasis Revenue Market Share by Countries in 2013
Figure North America Drugs for Schistosomiasis Revenue Market Share by Countries in 2017
Figure United States Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Canada Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Mexico Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table Europe Drugs for Schistosomiasis Sales by Countries (2013-2018)
Table Europe Drugs for Schistosomiasis Sales Market Share by Countries (2013-2018)
Table Europe Drugs for Schistosomiasis Revenue by Countries (2013-2018)
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Countries in 2016
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Countries in 2017
Figure Germany Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure UK Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure France Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Russia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Italy Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Schistosomiasis Sales by Countries (2013-2018)
Table Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Countries 2017
Table Asia-Pacific Drugs for Schistosomiasis Revenue by Countries (2013-2018)
Figure Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Countries 2017
Figure China Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Japan Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Korea Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure India Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure South America Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table South America Drugs for Schistosomiasis Sales by Countries (2013-2018)
Table South America Drugs for Schistosomiasis Sales Market Share by Countries (2013-2018)
Figure South America Drugs for Schistosomiasis Sales Market Share by Countries in 2017
Table South America Drugs for Schistosomiasis Revenue by Countries (2013-2018)
Table South America Drugs for Schistosomiasis Revenue Market Share by Countries (2013-2018)
Figure South America Drugs for Schistosomiasis Revenue Market Share by Countries in 2017
Figure Brazil Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Argentina Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Colombia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Schistosomiasis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Schistosomiasis Sales by Countries (2013-2018)
Table Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Countries in 2017
Table Middle East and Africa Drugs for Schistosomiasis Revenue by Countries (2013-2018)
Table Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Countries in 2013
Figure Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure UAE Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Egypt Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure Nigeria Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Figure South Africa Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
Table Global Drugs for Schistosomiasis Sales by Type (2013-2018)
Table Global Drugs for Schistosomiasis Sales Share by Type (2013-2018)
Table Global Drugs for Schistosomiasis Revenue by Type (2013-2018)
Table Global Drugs for Schistosomiasis Revenue Share by Type (2013-2018)
Figure Global Praziquantel Sales Growth (2013-2018)
Figure Global Praziquantel Price (2013-2018)
Figure Global Oxamniquine Sales Growth (2013-2018)
Figure Global Oxamniquine Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Drugs for Schistosomiasis Sales by Application (2013-2018)
Table Global Drugs for Schistosomiasis Sales Share by Application (2013-2018)
Figure Global S. mansoni Sales Growth (2013-2018)
Figure Global S. japonicum Sales Growth (2013-2018)
Figure Global S. mekongi Sales Growth (2013-2018)
Figure Global S. intercalatum Sales Growth (2013-2018)
Figure Global Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2018-2023)
Table Global Drugs for Schistosomiasis Sales Forecast by Regions (2018-2023)
Table Global Drugs for Schistosomiasis Market Share Forecast by Regions (2018-2023)
Figure North America Sales Drugs for Schistosomiasis Market Forecast (2018-2023)
Figure Europe Sales Drugs for Schistosomiasis Market Forecast (2018-2023)
Figure Asia-Pacific Sales Drugs for Schistosomiasis Market Forecast (2018-2023)
Figure South America Sales Drugs for Schistosomiasis Market Forecast (2018-2023)
Figure Middle East and Africa Sales Drugs for Schistosomiasis Market Forecast (2018-2023)
Table Global Drugs for Schistosomiasis Sales Forecast by Type (2018-2023)
Table Global Drugs for Schistosomiasis Market Share Forecast by Type (2018-2023)
Table Global Drugs for Schistosomiasis Sales Forecast by Application (2018-2023)
Table Global Drugs for Schistosomiasis Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Enquiry Before Buying

*

*
*
*
*
*

Request Sample


*

*
*
*
*
*